Endoplasmic reticulum-mitochondria contact sites: a new prognostic marker for prostate cancer?

Research output: Contribution to conferencePoster

Original languageEnglish
Publication statusPublished - 2018
EventEMBO Membrane Contact Sites in Health and Disease - Arosa, Switzerland
Duration: 21 Oct 201925 Oct 2019

Conference

ConferenceEMBO Membrane Contact Sites in Health and Disease
CountrySwitzerland
CityArosa
Period21/10/201925/10/2019

Cite this

Evergren, E. (2018). Endoplasmic reticulum-mitochondria contact sites: a new prognostic marker for prostate cancer?. Poster session presented at EMBO Membrane Contact Sites in Health and Disease, Arosa, Switzerland.
Evergren, Emma. / Endoplasmic reticulum-mitochondria contact sites: a new prognostic marker for prostate cancer?. Poster session presented at EMBO Membrane Contact Sites in Health and Disease, Arosa, Switzerland.
@conference{43336a6ee0a342149afd7c062729e91d,
title = "Endoplasmic reticulum-mitochondria contact sites: a new prognostic marker for prostate cancer?",
author = "Emma Evergren",
year = "2018",
language = "English",
note = "EMBO Membrane Contact Sites in Health and Disease ; Conference date: 21-10-2019 Through 25-10-2019",

}

Evergren, E 2018, 'Endoplasmic reticulum-mitochondria contact sites: a new prognostic marker for prostate cancer?', EMBO Membrane Contact Sites in Health and Disease, Arosa, Switzerland, 21/10/2019 - 25/10/2019.

Endoplasmic reticulum-mitochondria contact sites: a new prognostic marker for prostate cancer? / Evergren, Emma.

2018. Poster session presented at EMBO Membrane Contact Sites in Health and Disease, Arosa, Switzerland.

Research output: Contribution to conferencePoster

TY - CONF

T1 - Endoplasmic reticulum-mitochondria contact sites: a new prognostic marker for prostate cancer?

AU - Evergren, Emma

PY - 2018

Y1 - 2018

M3 - Poster

ER -

Evergren E. Endoplasmic reticulum-mitochondria contact sites: a new prognostic marker for prostate cancer?. 2018. Poster session presented at EMBO Membrane Contact Sites in Health and Disease, Arosa, Switzerland.